Literature DB >> 14731679

JAK protein tyrosine kinases: their role in cytokine signalling.

A Ziemiecki1, A G Harpur, A F Wilks.   

Abstract

Protein tyrosine kinases (PTKs) are integral components of the cellular machinery that mediates the transduction and/or processing of many extra- and intracellular signals. Members of the JAK family of intracellular PTKs (JAK1, JAK2 and TYK2) are characterized by the possession of a PTK-related domain and five additional homology domains, in addition to a classical PTK domain. An important breakthrough in the understanding of JAK kinases function(s) has come from the recent observations that many cytokine receptors compensate for their lack of a PTK domain by utilizing members of the JAK family for signal transduction.

Entities:  

Year:  1994        PMID: 14731679     DOI: 10.1016/0962-8924(94)90143-0

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  16 in total

1.  Regulation of the Jak2 tyrosine kinase by its pseudokinase domain.

Authors:  P Saharinen; K Takaluoma; O Silvennoinen
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain.

Authors:  Pipsa Saharinen; Mauno Vihinen; Olli Silvennoinen
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

3.  The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.

Authors:  M C Gauzzi; G Barbieri; M F Richter; G Uzé; L Ling; M Fellous; S Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Modulation of growth factor receptor function by isoform heterodimerization.

Authors:  W P Chang; C V Clevenger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.

Authors:  M L Vignais; H B Sadowski; D Watling; N C Rogers; M Gilman
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

6.  Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results.

Authors:  M Bolla; B Rostaing-Puissant; S P Bottari; M Chedin; J Marron-Charriere; M Colonna; E Berland; E Chambaz
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons.

Authors:  H J Fülle; R Vassar; D C Foster; R B Yang; R Axel; D L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

8.  Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy.

Authors:  K D O'Neal; M V Chari; C H Mcdonald; R G Cook; L Y Yu-Lee; J D Morrisett; W T Shearer
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

9.  JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitors.

Authors:  Alexandra Dusa; Céline Mouton; Christian Pecquet; Murielle Herman; Stefan N Constantinescu
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

Review 10.  Sensitivity and resistance of JAK2 inhibitors to myeloproliferative neoplasms.

Authors:  Neha Bhagwat; Ross L Levine; Priya Koppikar
Journal:  Int J Hematol       Date:  2013-05-14       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.